Author of the publication

Tumor-targeted costimulation with antibody-fusion proteins improves bispecific antibody-mediated immune response in presence of immunosuppressive factors

, , , and . Oncoimmunology, 6 (12): e1361594 (2017)
DOI: 10.1080/2162402X.2017.1361594

Please choose a person to relate this publication to

To differ between persons with the same name, the academic degree and the title of an important publication will be displayed. You can also use the button next to the name to display some publications already assigned to the person.

 

Other publications of authors with the same name

Advancing targeted co-stimulation with antibody-fusion proteins by introducing TNF superfamily members in a single-chain format, , , , , , and . OncoImmunology, 5 (11): e1238540 (2016)IL15-Based Trifunctional Antibody-Fusion Proteins with Costimulatory TNF-Superfamily Ligands in the Single-Chain Format for Cancer Immunotherapy, , , , and . Molecular Cancer Therapeutics, 18 (7): 1278-1288 (2019)Tumor-targeted costimulation with antibody-fusion proteins improves bispecific antibody-mediated immune response in presence of immunosuppressive factors, , , and . OncoImmunology, 6 (12): e1361594 (December 2017)Influence of antigen density and immunosuppressive factors on tumor-targeted costimulation with antibody-fusion proteins and bispecific antibody-mediated T cell response, , , and . Cancer Immunology Immunotherapy, (2020)Diabody-Ig: a novel platform for the generation of multivalent and multispecific antibody molecules, , , , and . mAbs, 11 (5): 919-929 (2019)IL-15-based trifunctional antibody-fusion proteins with costimulatory TNF-superfamily ligands in the single-chain format for cancer immunotherapy, , , , and . Molecular Cancer Therapeutics, (April 2019)Advancing targeted co-stimulation with antibody-fusion proteins by introducing TNF superfamily members in a single-chain format, , , , , , and . OncoImmunology, 5 (11): e1238540 (November 2016)Tumor-targeted costimulation with antibody-fusion proteins improves bispecific antibody-mediated immune response in presence of immunosuppressive factors, , , and . Oncoimmunology, 6 (12): e1361594 (2017)IL-15-based trifunctional antibody-fusion proteins with costimulatory TNF-superfamily ligands for cancer immunotherapy. Universität Stuttgart, Stuttgart, Dissertation, (2018)